Jafar Golzarian, MD
Vascular & Interventional Radiology · Golden Valley, MNNPI 1093703944
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.1%), other and speaking fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 46.9% of the total. Reporting peaked in 2022 at $201,397 and has fallen 70.2% since, to $59,966 in 2025. Among vascular & interventional radiology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 339 payments — averaging $1478.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$235K
- Medtronic$58K
- GE HealthCare$56K
- Penumbra, Inc.$47K
- Terumo Medical Corporation$23K
- Siemens Medical Solutions USA, Inc.$13K
- plus $69K from 28 others
Across 33 payments — averaging $6526.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Guerbet LLC$66K
- GE HealthCare$63K
- Sirtex Medical Inc$57K
- Bard Peripheral Vascular, Inc.$28K
- Medtronic$550
Across 2 payments — averaging $2100.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Shape Memory Medical Inc.$4K
What the payments were for
- Consulting fees$181,01536%
- Speaking & faculty fees$131,04326%
- Travel & lodging$22,3614%
- Food & beverage$12,0672%
- Education$600%
- Other$154,70131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 84 | $235,058 |
| Medtronic(2 entities) | 59 | $57,672 |
| GE HealthCare | 41 | $55,794 |
| Penumbra, Inc. | 35 | $46,643 |
| Terumo Medical Corporation | 18 | $23,430 |
| Siemens Medical Solutions USA, Inc. | 12 | $13,226 |
| Balt USA, LLC | 8 | $12,621 |
| Varian Medical Systems, Inc. | 3 | $11,470 |
| Sirtex Medical Inc | 14 | $10,604 |
| Instylla, Inc. | 1 | $8,800 |
| Okami Medical, Inc. | 7 | $8,640 |
| Heraeus Medical Components, LLC | 4 | $3,618 |
| Asahi Intecc USA, Inc. | 14 | $3,327 |
| Bard Peripheral Vascular, Inc. | 6 | $3,072 |
| Cook Incorporated | 1 | $3,050 |
| Mediview XR, Inc. | 1 | $1,400 |
| Guerbet LLC | 1 | $674 |
| Shape Memory Medical Inc. | 3 | $666 |
| Merit Medical Systems Inc | 3 | $365 |
| Argon Medical Devices, Inc. | 8 | $343 |
| Biocompatibles, Inc. | 2 | $186 |
| Atricure, Inc. | 1 | $178 |
| Angiodynamics, Inc. | 1 | $156 |
| Organogenesis Inc. | 2 | $64 |
| BTG International Canada Inc. | 1 | $47 |
| Histosonics, Inc. | 1 | $23 |
| Trisalus Life Sciences, Inc. | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Cook Medical LLC | 1 | $17 |
| Cordis US CORP. | 1 | $15 |
| Inari Medical, Inc. | 1 | $14 |
| Heraeus Medical, LLC. | 1 | $8 |
| ABK Biomedical USA, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$144,119
- Penumbra Ruby Coil$53,195
- TheraSphere Y90 Glass Microspheres 10 GBq$29,760
- GENERAL EMBOLICS$18,100
- Azur CX Detachable$13,800
- RUBY Coil$10,942
- SIR-Spheres Microspheres$10,544
- LOBO$8,529
- MVP$8,000
- General - Interventional Oncology$8,000
- ANGIO-SEAL$8,000
- Concerto$7,650
- ONYX 18$7,425
- Concerto Versa$4,950
- Indigo System$4,654
- IN.PACT Admiral$4,050
- ALLIA$3,292
- Abre$3,091
- Cook$3,050
- Asahi Interventional Radiology Wires$2,688
How this compares
$501,247 in reported general payments places this provider in the 95th percentile of 78 vascular & interventional radiology providers in Minnesota.
See all vascular & interventional radiology providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 80 | $521 |
| Ciprofloxacin Hcl | 60 | $308 |
| Oxybutynin Chloride | 58 | $171 |
| Ibuprofen | 50 | $149 |
| Omeprazole | 44 | $73 |
| Naproxen | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Golden Valley
- Seyed AstaniGolden Valley$14K
- Michael RosenbergMinneapolis$134K
- Andrew ThoresonPlymouth$129K
- Reza TalaieMinneapolis$64K
- Michael CummingSartell$60K
- Bjorn EngstromMinneapolis$55K
- Sandra NewberryEden Prairie$41K
- Sameer GadaniMinneapolis$33K
- Donna DsouzaMinneapolis$29K
- Christopher StampePlymouth$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.